Dalcetrapib
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for Dalcetrapib, covering 2014-11-03 to 2026-01-07. Get the full timeline:
Most recent: Clinical Trial Update: Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS [Phase 3]